Jushi Holdings (JUSHF) Depreciation & Amortization (CF) (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Depreciation & Amortization (CF) of $9.2 million for Q2 2026, up 15.88% year-over-year from $8.0 million in Q2 2025, and up 16.18% quarter-over-quarter from $7.9 million in Q1 2026.
Jushi Holdings (JUSHF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $9.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 15.88% year-over-year to $9.2 million; the TTM figure through Jun 2026 stood at $32.2 million (up 1.53% YoY), while the FY2025 annual figure was $31.0 million, up 3.68% from the prior year.
- Depreciation & Amortization (CF) grew to $9.2 million in Q2 2026 per JUSHF's latest filing, from $7.9 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $10.8 million in Q4 2022 and bottomed at $3.2 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $7.3 million across 5 years, with a median of $7.6 million in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 261.76% — and 2023, when it sank 37.13%.
- Jushi Holdings' Depreciation & Amortization (CF) stood at $10.8 million in 2022, then sank by 37.13% to $6.8 million in 2023, then increased by 16.16% to $7.9 million in 2024, then retreated by 9.08% to $7.2 million in 2025, then increased by 28.4% to $9.2 million in 2026.
- Business Quant data shows JUSHF's Depreciation & Amortization (CF) at $9.2 million in Q2 2026, $7.9 million in Q1 2026, and $7.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 9.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.23 Mn |
| Jun 30, 2026 | 9.23 Mn |
| Mar 31, 2026 | 7.95 Mn |
| Mar 31, 2026 | 7.95 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Sep 30, 2024 | 7.77 Mn |
| Sep 30, 2024 | 7.77 Mn |
| Jun 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 7.38 Mn |
| Mar 31, 2024 | 6.84 Mn |
| Mar 31, 2024 | 6.84 Mn |